A clinical study investigating the preheparin LPL mass in patients with coronary atherosclerosis showed that the amount of preheparin serum LPL was significantly lower in patients with coronary atherosclerosis, which was negatively correlated with triglycerides and positively correlated with HDL cholesterol [25]. This evidence concerns the gene LPL and coronary atherosclerosis.